Notwithstanding the medium-term gains, the acquisition of JB Chemicals & Pharmaceuticals brings uncertainty over successful ...

Prabhudas Lilladher recommended accumulate rating on Torrent Pharmaceuticals with a target price of Rs 3850 in its research ...

According to Nuvama Institutional Equities, TRP will initially acquire a 46.39 per cent stake in JBCP from private equity ...

ICICI Securities recommended hold rating on Torrent Pharma with a target price of Rs 3500 in its research report dated July ...

Torrent Pharmaceuticals Ltd. received a share price target upgrade from BofA Securities, on the likely synergies in operating ...

Following the acquisition of JB Chemicals & Pharmaceuticals (JB Chem), Torrent Pharma is set to become India's fifth-largest ...

Torrent Pharma will emerge among the top 5 domestic pharma players by sales with the acquisition of J B Chemicals and ...

Shares of J B Chemicals dropped nearly 7% after Torrent Pharma announced acquiring a majority stake for Rs 19,500 crore, set to make it India's second top pharma company. Torrent Pharma's shares ...

This news roundup covers significant developments in the health industry, including France's Carmat filing for insolvency, ...

The brokerage firm Motilal Oswal has reiterated a “Neutral” stance on Torrent Pharma, assigning a price target of Rs 3,430. This translated to 3% above the current market price. The brokerage call ...

"Overall timeline for completion of the transaction: 15-18 months," Torrent Pharmaceuticals said in an investor presentation on the BSE. The company would mainly need approvals for the deal from the ...

The deal grants Torrent Pharma access to a thriving pharmaceutical business. JB Pharma makes drugs for gastroenterology, ...